Vitamin B5 (Pantothenic Acid) for Cholesterol Management

Research suggests a potential link between pantothenic acid levels and cholesterol management, particularly regarding HDL ("good") cholesterol, based on observational findings in patients with obesity, type 2 diabetes, and cardiovascular complications. The available evidence consists of a single observational study from 2025, which found that lower blood levels of pantothenic acid were associated with reduced HDL cholesterol, poorer blood sugar control, and higher odds of having both type 2 diabetes and cardiovascular disease. While this directionally supports a role for pantothenic acid in metabolic and cardiovascular health, the observational nature of the study means it cannot establish that low pantothenic acid causes these outcomes, only that the two are associated. The overall evidence base is quite limited at this stage, and the researchers themselves note that supplementation approaches would need further investigation before meaningful conclusions about therapeutic benefit can be drawn.